Impact of plasmid stability on oral DNA delivery by Salmonella enterica serovar Typhimurium
- PMID: 17126961
- DOI: 10.1016/j.vaccine.2006.10.042
Impact of plasmid stability on oral DNA delivery by Salmonella enterica serovar Typhimurium
Abstract
Live attenuated Salmonellae may overcome limitations with conventional methods of DNA immunisation. This study examined the impact of plasmid stability on oral DNA delivery by the attenuated Salmonella enterica serovar Typhimurium vaccine strain BRD509. A DNA vaccine cassette comprising the C fragment of tetanus toxin under control of the cytomegalovirus (CMV) promoter was ligated into plasmid pcDNA3, pUC18, pBBR122, pACYC184, pRSF1010/CAT, pBR322 and pAT153. In vitro and in vivo stability studies revealed that, with the exception of pcDNA3 and pUC18, the plasmids were retained by BRD509. However, pAT153 was the only plasmid to induce a tetanus toxoid-specific antibody response following oral delivery. Plasmid copy number was found to impact on plasmid stability and the induction of antigen-specific humoral responses.
Similar articles
-
Impact of prior immunological exposure on vaccine delivery by Salmonella enterica serovar Typhimurium.Vaccine. 2008 Nov 18;26(49):6212-20. doi: 10.1016/j.vaccine.2008.09.060. Epub 2008 Oct 11. Vaccine. 2008. PMID: 18852007
-
In vitro and in vivo stability of recombinant plasmids in a vaccine strain of Salmonella enterica var. Typhimurium.FEMS Immunol Med Microbiol. 2003 Jul 15;37(2-3):111-9. doi: 10.1016/S0928-8244(03)00065-8. FEMS Immunol Med Microbiol. 2003. PMID: 12832114
-
Genetic detoxification of an aroA Salmonella enterica serovar Typhimurium vaccine strain does not compromise protection against virulent Salmonella and enhances the immune responses towards a protective malarial antigen.FEMS Immunol Med Microbiol. 2008 Mar;52(2):237-46. doi: 10.1111/j.1574-695X.2007.00368.x. Epub 2008 Jan 3. FEMS Immunol Med Microbiol. 2008. PMID: 18177343
-
The use of live attenuated Salmonella for oral vaccination.Dev Biol Stand. 1994;82:35-42. Dev Biol Stand. 1994. PMID: 7958481 Review.
-
Rational design of Salmonella recombinant vaccines.Int J Med Microbiol. 2008 Jan;298(1-2):87-98. doi: 10.1016/j.ijmm.2007.08.006. Epub 2007 Sep 20. Int J Med Microbiol. 2008. PMID: 17888730 Review.
Cited by
-
Tumor-specifically hypoxia-induced therapy of SPRY1/2 displayed differential therapeutic efficacy for melanoma.Am J Cancer Res. 2015 Jan 15;5(2):792-801. eCollection 2015. Am J Cancer Res. 2015. PMID: 25973316 Free PMC article.
-
Two Novel Salmonella Bivalent Vaccines Confer Dual Protection against Two Salmonella Serovars in Mice.Front Cell Infect Microbiol. 2017 Sep 4;7:391. doi: 10.3389/fcimb.2017.00391. eCollection 2017. Front Cell Infect Microbiol. 2017. PMID: 28929089 Free PMC article.
-
Proteomic screening of anaerobically regulated promoters from Salmonella and its antitumor applications.Mol Cell Proteomics. 2011 Jun;10(6):M111.009399. doi: 10.1074/mcp.M111.009399. Epub 2011 Apr 7. Mol Cell Proteomics. 2011. PMID: 21474796 Free PMC article.
-
Tumor-targeted delivery of a C-terminally truncated FADD (N-FADD) significantly suppresses the B16F10 melanoma via enhancing apoptosis.Sci Rep. 2016 Oct 21;6:34178. doi: 10.1038/srep34178. Sci Rep. 2016. PMID: 27767039 Free PMC article.
-
Development of non-antibiotic-resistant, chromosomally based, constitutive and inducible expression systems for aroA-attenuated Salmonella enterica Serovar Typhimurium.Infect Immun. 2009 May;77(5):1817-26. doi: 10.1128/IAI.01301-08. Epub 2009 Feb 17. Infect Immun. 2009. PMID: 19223478 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous